COMPARE - Comprehensive Morbidity PostCovid Assessment using Registries

The COMPARE project is a multidisciplinary effort to provide novel and comprehensive knowledge on the post-acute sequelae of COVID-19 (PASC) and generate data driven evidence to COVID-19 epidemics.

The project includes optimally reliable and efficient epidemiological studies based on the high-quality nationwide Swedish register, and the COMPARE focuses on four work streams: 1) to assess the disease burden and clustering of PASC leveraging unique resources of SARS-CoV-2 Quality Assurance Registry 2) to understand the risk factors of PASC, how the clinical features of COVID-19 and virological features of SARS-CoV-2 interacts and its relation to long-term risk of PASC as well as in comparison with other virus infections 3) to evaluate the impact of COVID-19 vaccination on the risk of PASC 4) to examine the long-term risk of PASC using artificial intelligence technique and elucidate the impact of the variants of concerns on PASC through an international collaboration.

COMPARE ensures that Sweden becomes a major participant in the international evaluation of PASC by being a prominent partner in the EU COVID-19 project EuCARE.The COMPARE project has assembled a competitive and multidisciplinary collaboration within Sweden and beyond.

COMPARE aims to become an world-leading research project on COVID-19 and generate cutting edge evidence for PASC, which can help to develop effective preventive strategies and design health services tailored to address the syndrome.